You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Latest News
Inovio Pharmaceuticals Inc reports H1 results
10 August 2012 - Inovio Pharmaceuticals Inc (NYSE MKT: INO), a company that produces vaccines to prevent and treat today's cancers and challenging infectious diseases, has today reported its financial results for the six months ended 30 June 2012.

The company posted total revenue at US...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up

 

 

 

Login
Username:

Password:


Related Headlines

Acorda Therapeutics receives US patent for ampyra

R-Tech Ueno starts patient enrolment in Phase I/II severe dry eye

Steribeam announces results of six logs sterilisation of B pumilus spores

AbbVie starts Phase 3 study of atrasentan in diabetic nephropathy patients

GlaxoSmithKline plans to close tablet-packaging facility in Melbourne

Jennerex Biotherapeutics completes enrolment of 120 patients in Phase 2b trial of Pexa-Vec

Valeant Pharmaceuticals International launches new international headquarters in Canada

Avion Pharmaceuticals launches Prenate Chewable

US Organic Group develops Anti Itchbalm

GlaxoSmithKline collaborates with Biomedical Advanced Research and Development Authority

Corgenix Medical collaborates with Eli Lilly

R-Tech Ueno receives FDA approval for RU-101 ophthalmic solution

Soligenix receives US patent for ThermoVax

Merck sells Geneva headquarters

Duchesnay USA introduces Diclegis in US pharmacies

Designed by Create Marketing
Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2013